Market Cap : 465.34 M | Enterprise Value : 939.56 M | PE Ratio : At Loss | PB Ratio : 0.61 |
---|
NAS:ZIMV has been successfully added to your Stock Email Alerts list.
You can manage your stock email alerts here.
NAS:ZIMV has been removed from your Stock Email Alerts list.
Please enter Portfolio Name for new portfolio.
EV-to-EBIT is calculated as Enterprise Value divided by its EBIT. As of today, ZimVie's Enterprise Value is $939.6 Mil. ZimVie's EBIT for the trailing twelve months (TTM) ended in Jun. 2022 was $-149.6 Mil. Therefore, ZimVie's EV-to-EBIT for today is -6.28.
The historical rank and industry rank for ZimVie's EV-to-EBIT or its related term are showing as below:
During the past 4 years, the highest EV-to-EBIT of ZimVie was -5.94. The lowest was -9.17. And the median was -8.18.
Joel Greenblatt calls the inversion of this ratio Earnings Yield (Joel Greenblatt) %. ZimVie's Enterprise Value for the quarter that ended in Jun. 2022 was $891.8 Mil. ZimVie's EBIT for the trailing twelve months (TTM) ended in Jun. 2022 was $-149.6 Mil. ZimVie's Earnings Yield (Joel Greenblatt) % for the quarter that ended in Jun. 2022 was -16.78%.
The historical data trend for ZimVie's EV-to-EBIT can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Medical Devices subindustry, ZimVie's EV-to-EBIT, along with its competitors' market caps and EV-to-EBIT data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
For the Medical Devices & Instruments industry and Healthcare sector, ZimVie's EV-to-EBIT distribution charts can be found below:
* The bar in red indicates where ZimVie's EV-to-EBIT falls into.
ZimVie's EV-to-EBIT for today is calculated as:
EV-to-EBIT | = | Enterprise Value (Today) | / | EBIT (TTM) |
= | 939.559 | / | -149.627 | |
= | -6.28 |
ZimVie's current Enterprise Value is $939.6 Mil.
ZimVie's EBIT for the trailing twelve months (TTM) ended in Jun. 2022 adds up the quarterly data reported by the company within the most recent 12 months, which was $-149.6 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
This is a more accurate valuation of companies' operation because it considers the debt and cash on its balance sheet, and non-operating items such as interest payment, tax, and one-time items are not included in the Operating Income.
Joel Greenblatt calls the inversion of this ratio Earnings Yield (Joel Greenblatt) %.
ZimVie's Earnings Yield (Joel Greenblatt) % for the quarter that ended in Jun. 2022 is calculated as:
Earnings Yield (Joel Greenblatt) % (Q: Jun. 2022 ) | = | EBIT | / | Enterprise Value (Q: Jun. 2022 ) |
= | -149.627 | / | 891.79282 | |
= | -16.78 % |
ZimVie's Enterprise Value for the quarter that ended in Jun. 2022 was $891.8 Mil.
ZimVie's EBIT for the trailing twelve months (TTM) ended in Jun. 2022 adds up the quarterly data reported by the company within the most recent 12 months, which was $-149.6 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Thank you for viewing the detailed overview of ZimVie's EV-to-EBIT provided by GuruFocus.com. Please click on the following links to see related term pages.
Crawford Sally | director | C/O HOLOGIC, INC. BEDFORD MA 01730 |
Kuntz Richard | director | MEDTRONIC, INC. 710 MEDTRONIC PWKY MS LC 310 MINNEAPOLIS MN 55432 |
Asar Vinit K | director | 10910 DOMAIN DRIVE, SUITE 300 AUSTIN TX 78758 |
Matusinec Karen | director | C/O ZIMVIE INC. 10225 WESTMOOR DRIVE WESTMINSTER CO 80021 |
King David P | director | PRIVIA HEALTH GROUP, INC. 950 N. GLEBE RD., SUITE 700 ARLINGTON VA 22203 |
Zimmer Biomet Holdings, Inc. | 10 percent owner | 345 EAST MAIN STREET WARSAW IN 46580 |
Whitney Rebecca Ann | officer: See Remarks | 10225 WESTMOOR DRIVE WESTMINSTER CO 80021 |
Harmon David John | officer: See Remarks | 10225 WESTMOOR DRIVE WESTMINSTER CO 80021 |
Jamali Vafa | director, officer: See Remarks | C/O ZIMVIE INC. 10225 WESTMOOR DRIVE WESTMINSTER CO 80021 |
Kanaglekar Indraneel | officer: See Remarks | C/O ZIMVIE INC. 10225 WESTMOOR DRIVE WESTMINSTER CO 80021 |
Kidwell Heather | officer: See Remarks | C/O ZIMVIE INC. 10225 WESTMOOR DRIVE WESTMINSTER CO 80021 |
Schneider Sandra | officer: Chief Accounting Officer | C/O ZIMVIE INC. 10225 WESTMOOR DRIVE WESTMINSTER CO 80021 |
Heppenstall Richard | officer: See Remarks | C/O ZIMVIE INC. 10225 WESTMOOR DRIVE WESTMINSTER CO 80021 |
From GuruFocus
Other Sources